Chesnara Plc: Fourth acquisition in two years
12 November 2026
Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to treating severe autoimmune and..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is making waves in the biotechnology sector, with a remarkable potential upside of 494.44%, according to analyst ratings. As a commercial-stage..
For investors eyeing the biotechnology sector, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) stands out as a compelling opportunity, underpinned by significant analyst confidence and an impressive..
AMN Healthcare Services Inc (NYSE: AMN), a key player in the medical care facilities industry, is attracting investor interest with a potential upside of 32.15%. As..
Arcus Biosciences, Inc. (NASDAQ: RCUS) presents a compelling opportunity for investors with a striking potential upside of 192.65%, according to the latest analyst ratings. This clinical-stage..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) is making waves in the biotechnology sector with its innovative approach to addressing unmet medical needs in cancer treatment. Based in..
Nutex Health Inc. (NASDAQ: NUTX) stands out in the healthcare sector, not just for its innovative approach to medical care facilities but also for the striking..
In the dynamic world of biotechnology, Replimune Group, Inc. (NASDAQ: REPL) stands out as a promising player. With its focus on developing cutting-edge oncolytic immunotherapies to..
Geron Corporation (NASDAQ: GERN), a biopharmaceutical company specializing in oncology therapeutics, is capturing the attention of investors with its ambitious growth potential and significant projected upside...
Cogent Biosciences, Inc. (NASDAQ: COGT) stands out in the biotechnology sector with a compelling narrative that promises significant upside potential for investors. With a market capitalization..
Sionna Therapeutics, Inc. (NASDAQ: SION), a trailblazer in the biotechnology sector, is capturing the attention of investors with its promising portfolio of cystic fibrosis (CF) treatments...
Investors with an eye for high-growth potential in the biotechnology sector should take a closer look at AbCellera Biologics Inc. (NASDAQ: ABCL), a pioneering company dedicated..
Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology company headquartered in Waltham, Massachusetts, is capturing the attention of investors with its promising pipeline in the healthcare sector. With..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a late-stage biotechnology firm, is making headlines with a potential upside of 242.96%, according to the latest analyst ratings. With a..
Embecta Corp. (EMBC), a distinguished player in the healthcare sector, specializes in medical instruments and supplies with a pronounced focus on diabetes management solutions. With a..
For investors with an eye on the healthcare sector, Pharming Group N.V. (PHAR) represents a compelling opportunity within the biotechnology industry. Headquartered in Leiden, Netherlands, Pharming..
For investors with a keen eye on the healthcare sector, Arbutus Biopharma Corporation (NASDAQ: ABUS) presents an intriguing opportunity. This clinical-stage biopharmaceutical company is leading the..
Savara, Inc. (SVRA), a clinical-stage biopharmaceutical company specializing in rare respiratory diseases, is capturing the attention of investors with its impressive potential for growth. Despite its..
Nurix Therapeutics, Inc. (NRIX), a prominent player in the biotechnology sector, has been garnering considerable attention from investors, thanks to its promising pipeline and strategic collaborations...
In the ever-evolving landscape of medical devices, InMode Ltd. (NASDAQ: INMD) stands out with its innovative approach to aesthetic medical technologies. Headquartered in Yokne’am, Israel, and..
